(Boursier.com) — AB Science SA will hold a virtual conference on Thursday, November 30, from 3 p.m. to 4 p.m., to present the clinical development program for masitinib in sickle cell disease.
During the virtual conference, AB Science will present:
– sickle cell disease and the scientific rationale for the use of masitinib in this indication
– the medical need and market potential in this indication
– the description of the Sickmast project
This conference will be followed by a question-and-answer session.
©2023 Boursier.com